Crossmark

De-risking Biopharma Asset Acquisition: Towards a Quantitative Framework for Strategic Decision-making

Crossref DOI link: https://doi.org/10.1208/s12248-026-01246-7

Published Online: 2026-05-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Xiaotang

Lu, Zheng

Zhao, Yating

Sheng, Jennifer https://orcid.org/0000-0002-3044-285X
License Information

Text and Data Mining valid from 2026-05-06

Version of Record valid from 2026-05-06
More Information

Article History

Received: 23 December 2025

Accepted: 14 April 2026

First Online: 6 May 2026

Declarations

:

: No conflict of interests for any co-authors.